[Applications of genetically modified animals].
The first transgenic animals, mice, were obtained in 1980. The techniques of gene transfer had to be adapted to obtain transgenic animals with an acceptable yield in about fifteen species. When the yield is low (low rate of random integration and targeted integration via homologous recombination), genetic modifications must be achieved in intermediate cells able to participate to the development of chimeric transgenic animals (ES cells, EG cells, iPS obtained by the dedifferentiation of somatic cells) or in somatic cells used as nuclear donor to generate transgenic clones. Various tools make possible a marked increase of homologous recombination efficiency (meganucleases and ZFN), or a gene inactivation at the genome level (direct or conditional knock out) or at the mRNA level (interfering RNAs). Vectors allow a more reliable transgene expression. Genetically modified animals are used mainly to obtain information on biological functions and human diseases. Transgenic animals produce recombinant pharmaceutical proteins in milk and soon in egg white. Pig organs adapted to be tolerated by patients might be tested in humans in five years. The projects based on the use of transgenesis to improve animal production are presently few. Transgenic salmon with accelerated growth might be on the market when their possible escape in oceans will be controlled.
Houdebine
Louis-Marie
LM
louis.houdebine@jouy.inra.fr
D000818:Animals; D030801:Animals, Genetically Modified; D002645:Chickens / Q000235:genetics; D002678:Chimera; D005399:Fishes / Q000235:genetics; D005523:Food Supply; D030841:Food, Genetically Modified; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000302:isolation & purification; D012106:Research; D012418:Ruminants / Q000235:genetics; D014183:Transplantation, Heterologous
D011994:Recombinant Proteins